Opus Genetics | 4:持股變動聲明-高管 Zaremba Rabourn Amy
Opus Genetics | 4:持股變動聲明-高管 Hoffmann Bernhard
Opus Genetics | 4:持股變動聲明-董事 MANUSO JAMES S J
Opus Genetics | 4:持股變動聲明-董事 Bennett Jean
Opus Genetics | 4:持股變動聲明-高管 Magrath George
Opus Genetics | 4:持股變動聲明-高管 Magrath George
Opus Genetics | 4:持股變動聲明-高管 YERXA BENJAMIN R
Opus Genetics | 4:持股變動聲明-高管 Magrath George
Opus Genetics | 4:持股變動聲明-高管 YERXA BENJAMIN R
D:發行公告
4:持股變動聲明-高管 Magrath George
SC 13D:超過5%持股股東披露文件-Foundation Fighting Blindness Retinal Degeneration Fund(8.16%),Foundation Fighting Blindness, Inc.(8.16%)
3:首次持股聲明-董事 Foundation Fighting Blindness Retinal Degeneration Fund
4:持股變動聲明-董事 Graves Adrienne L
4:持股變動聲明-董事 Bennett Jean
3:首次持股聲明-高管 YERXA BENJAMIN R
3:首次持股聲明-董事 Graves Adrienne L
3:首次持股聲明-董事 Bennett Jean
Ocuphire Pharma | 4:持股變動聲明-董事 Rodgers Richard J
Ocuphire Pharma | 4:持股變動聲明-董事 Pepose Jay